Alzheimer’s /Dementia Global Landscape 2026
Alzheimer’s / Dementia — 2026 Global Landscape A World Economic Forum–Style Policy Brief Therapeutics | Biomarkers | Diagnostics | System Convergence Author: KJ Lavan https://www.linkedin.com/in/kj-lavan-1739ab226 ⸻ Executive Summary Alzheimer’s disease is entering a systems inflection point . After decades of scientific uncertainty, the field is transitioning from proof-of-concept breakthroughs to implementation architecture where who gets treated, when, and at what cost becomes the defining challenge.¹ ² Three forces are converging: • Therapeutics are moving toward precision, earlier intervention, and combinatorial approaches⁴ • Biomarkers are becoming the clinical and economic gatekeepers⁵ ⁶ • Diagnostics are evolving into scalable, multi-layer access systems³ This convergence is reshaping Alzheimer’s from a late-stage clinical condition into a longitudinal, biomarker-defined disease continuum w...